Singapore’s drug makers may be shielded from US tariffs: Deputy PM Gan

New US levies on pharmaceuticals may not have an “immediate impact” on Singapore’s drug makers, Deputy Prime Minister Gan Kim Yong has said, adding the city state may pursue a ceiling on tariff rates similar to deals that Washington has with other countries.
Gan, who is also minister for trade and industry, told reporters on Saturday that most pharmaceutical companies in Singapore had built capacity in the US or had plans to do so. That could allow them to be exempted from the coming US…